Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 2000-2099

2000. K. Suzuki, “Protein C inhibitor,” Methods Enzymol. 222(1993):385-399; S.T. Cooper, F.C. Church, “PCI: protein C inhibitor?” Adv. Exp. Med. Biol. 425(1997):45-54.

2001. M.G. Roback, A.M. Stack, C. Thompson, C. Brugnara, H.P. Schwarz, R.A. Saladino, “Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits,” Shock 9(February 1998):138-142.

2002. A.P. Betrosian, M. Balla, G. Kofinas, M. Papanikolaou, G. Georgiadis, “Protein C in the treatment of coagulopathy in memingococcal sepsis,” Crit. Care Med. 27(December 1999):2849-2850.

2003. Peter A. Mayes, “Metabolism of Acylglycerols and Sphingolipids,” in Robert K. Murray, Daryl K. Granner, Peter A. Mayes, Victor W. Rodwell, eds., Harper’s Biochemistry, 23rd Edition, Appleton & Lange, Norwalk CT, 1993, pp. 241-249.

2004. Clayton L. Thomas, ed., Taber’s Cyclopedic Medical Dictionary, 17th Edition, F.A. Davis Company, Philadelphia PA, 1989.

2005. Allan T. Luskin, “Allergic asthma,” in J. Willis Hurst, Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston, MA, 1992, pp. 169-171.

2006. R.W. Weber, “Allergens,” Prim. Care 14(September 1987):435-445.

2007. S.B. Lehrer, J.E. Salvaggio, “Allergens: standardization and impact of biotechnology – a review,” 11(September-October 1990):197-208.

2008. D.I. Bernstein, “Allergic reactions to workplace allergens,” JAMA 278(10 December 1997):1907-1913.

2009. H. Breiteneder, C. Ebner, “Molecular and biochemical classification of plant-derived food allergens,” J. Allergy Clin. Immunol. 106(July 2000):27-36.

2010. R. Valenta et al, “Profilins constitute a novel family of functional plant pan-allergens,” J. Exp. Med. 175(1 February 1992):377-385.

2011. S.B. Lehrer, W.E. Horner, G. Reese, “Why are some proteins allergenic? Implications for biotechnology,” Crit. Rev. Food Sci. Nutr. 36(July 1996):553-564.

2012. F. de Blay, G. Pauli, J.C. Bessot, “Cross-reactions between respiratory and food allergens,” Allergy Proc. 12(September-October 1991):313-317.

2013. D.H. Beezhold, G.L. Sussman, G.M. Liss, N.S. Chang, “Latex allergy can induce clinical reactions to specific foods,” Clin. Exp. Allergy 26(April 1996):416-422.

2014. K. Lammintausta, K. Kalimo, C.T. Jansen, “Experimental nickel sensitization in the guinea pig: comparison of different protocols,” Contact Dermatitis 12(May 1985):258-262.

2015. “Report on base metal alloys for crown and bridge applications: benefits and risks. Council on Dental Materials, Instruments, and Equipment,” J. Am. Dent. Assoc. 111(September 1985):479-483.

2016. T. Menne, “Quantitative aspects of nickel dermatitis. Sensitization and eliciting threshold concentrations,” Sci. Total Environ. 148(6 June 1994):275-281.

2017. D.J. Gawkrodger, “Nickel dermatitis: how much is safe?” Contact Dermatitis 35(November 1996):267-271.

2018. H.J. Schubert, “Airborne nickel dermatitis,” Contact Dermatitis 42(February 2000):118-119.

2019. J.C. Wataha, C.T. Hanks, “Biological effects of palladium and risk of using palladium in dental casting alloys,” J. Oral Rehabil. 23(May 1996):309-320.

2020. D.W. Berzins, I. Kawashima, R. Graves, N.K. Sarkar, “Electrochemical characteristics of high-Pd alloys in relation to Pd-allergy,” Dent. Mater. 16(1 July 2000):266-273.

2021. L. Kanerva, T. Estlander, R. Jolanki, “Bank clerk’s occupational allergic nickel and cobalt contact dermatitis from coins,” Contact Dermatitis 38(April 1998):217-218.

2022. H.F. Hildebrand, C. Veron, P. Martin, “Nickel, chromium, cobalt dental alloys and allergic reactions: an overview,” Biomaterials 10(October 1989):545-548.

2023. D.A. Basketter, G. Briatico-Vangosa, W. Kaestner, C. Lally, W.J. Bontinck, “Nickel, cobalt and chromium in consumer products: a role in allergic contact dermatitis?” Contact Dermatitis 28(January 1993):15-25.

2024. D.J. Gawkrodger, F.M. Lewis, M. Shah, “Contact sensitivity to nickel and other metals in jewelry reactors,” J. Am. Acad. Dermatol. 43(July 2000):31-36.

2025. S. Fregert, “Occupational dermatitis in a 10-year material,” Contact Dermatitis 1(1975):96-107.

2026. L. Budinger, M. Hertl, “Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview,” Allergy 55(February 2000):108-115.

2027. S.M. Wilkinson, A.H. Heagerty, J.S. English, “Hand dermatitis in the pottery industry,” Contact Dermatitis 26(February 1992):91-94.

2028. P. Pospiech, P. Rammelsberg, G. Goldhofer, W. Gernet, “All-ceramic resin-bonded bridges. A 3-dimensional finite-element analysis study,” Eur. J. Oral Sci. 104(August 1996):390-395.

2029. A. Motolese, M. Truzzi, A. Giannini, S. Seidenari, “Contact dermatitis and contact sensitization among enamellers and decorators in the ceramics industry,” Contact Dermatitis 28(February 1993):59-62.

2030. E. Young, “Contact hypersensitivity to metallic gold,” Dermatologica 149(1974):294-298.

2031. J.J. Hostynek, “Gold: an allergen of growing significance,” Food Chem. Toxicol. 35(August 1997):839-844.

2032. A. Larsson, H. Moller, B. Bjorkner, M. Bruze, “Morphology of endogenous flare-up reactions in contact allergy to gold,” Acta Derm. Venereol. 77(November 1997):474-479.

2033. T. Fischer, I. Rystedt, “Cobalt allergy in hard metal workers,” Contact Dermatitis 9(March 1983):115-121.

2034. D. Parker, J.L. Turk, “Contact sensitivity to arylate compounds in guinea pigs,” Contact Dermatitis 9(January 1983):55-60.

2035. B. Bjorkner, B. Niklasson, “Influence of the vehicle on elicitation of contact allergic reactions to acrylic compounds in the guinea pig,” Contact Dermatitis 11(November 1984):268-278.

2036. C.G. Mathias, “Allergic contact dermatitis from a nonbisphenol A epoxy in a graphite fiber reinforced epoxy laminate,” J. Occup. Med. 29(September 1987):754-755.

2037. J.T. Lear, A.H. Heagerty, B.B. Tan, A.G. Smith, J.S. English, “Transient re-emergence of oil of turpentine allergy in the pottery industry,” Contact dermatitis 35(September 1996):169-172.

2038. H.P. Schwarze, F. Giordano-Labadie, F. Loche, M.B. Gorguet, J. Bazex, “Delayed-hypersensitivity granulomatous reaction induced by blepharopigmentation with aluminum-silicate,” J. Am. Acad. Dermatol. 42(May 2000):888-891.

2039. K.K. Liippo, S.L. Anttila, O. Taikina-Aho, E.L. Ruokonen, S.T. Toivonen, T. Tuomi, “Hypersensitivity pneumonitis and exposure to zirconium silicate in a young ceramic tile worker,” Am. Rev. Respir. Dis. 148(October 1993):1089-1092.

2040. V.G. Artamonova, N.F. Kuznetsov, A.M. Kadyskina, “Functional indicators of individual sensitivity to silicate dust in workers of ceramic tile and claydite industry,” Med. Tr. Prom. Ekol. 11-12(1993):10-12. In Russian.

2041. A.O. Ransford, T. Morley, M.A. Edgar, P. Webb, N. Massuti, D. Chopin, C. Morin, F. Michel, C. Garin, D. Pries, “Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients,” J. Bone Joint Surg. Br. 80(January 1998):13-18; 80(May 1998):562 (erratum).

2042. R. Cavagna, G. Daculsi, J.M. Bouler, “Macroporous calcium phosphate ceramic: a prospective study of 106 cases in lumbar spinal fusion,” J. Long Term Eff. Med. Implants 9(1999):403-412.

2043. K. Urban, J. Stehlik, “Initial clinical experience with BAS O, a bioactive glass-ceramic material,” Acta Chir. Orthop. Traumatol. Cech. 60(1993):40-60. In Czech.

2044. J.L. Charissoux, A. Najid, J.C. Moreau, D. Setton, M. Rigaud, “Development of in vitro biocompatibility assays for surgical material,” Clin. Orthop. 326(May 1996):259-269.

2045. T. Matsunaga, A. Shigematsu, N. Nakamura, “Detection of rat basophilic leukemia by cyclic voltammetry for monitoring allergic reaction,” Anal. Chem. 61(15 November 1989):2471-2474; N. Nakamura, I. Inoue, Y. Kitajima, T. Matsunaga, T. Chiba, T. Honda, “Detection of human leucocytes by cyclic voltammetry and its application to monitoring of allergic reaction,” Biosens. Bioelectron. 6(1991):431-437; N. Nakamura, S. Kumazawa, T. Matsunaga, “In vitro electrochemical detection of wheat allergen using rat basophilic leukaemia (RBL-1) cells,” Appl. Microbiol. Biotechnol. 43(August-September 1995):622-625.

2046. C. Sella, J.C. Martin, J. Lecoeur, J.P. Bellier, M.F. Harmand, A. Naji, J.P. Davidas, A. Le Chanu, “Corrosion protection of metal implants by hard biocompatible ceramic coatings deposited by radiofrequency sputtering,” Clin. Mater. 5(1990):297-307.

2047. G. Szabo, L. Kovacs, K. Vargha, J. Barabas, Z. Nemeth, “A new advanced surface modification technique – titanium oxide ceramic surface implants: the background and long-term results,” J. Long Term Eff. Med. Implants 9(1999):247-259.

2048. N. Martin, N.M. Jedynakiewicz, “Clinical performance of CEREC ceramic inlays: a systematic review,” Dent. Mater. 15(January 1999):54-61.

2049. M.A. Bergman, “The clinical performance of ceramic inlays: a review,” Aust. Dent. 44(September 1999):157-168.

2050. H. Erpenstein, R. Borchard, T. Kerschbaum, “Long-term clinical results of galvano-ceramic and glass-ceramic individual crowns,” J. Prosthet. Dent. 83(May 2000):530-534.

2051. M. Thordrup, F. Isidor, P. Horsted-Bindslev, “A 3-year study of inlays milled from machinable ceramic blocks representing 2 different inlay systems,” Quintessence Int. 30(December 1999):829-836.

2052. C. Warren Bierman, “Anaphylaxis,” in J. Willis Hurst, Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston, MA, 1992, pp. 165-169.

2053. L.B. Schwartz, R.A. Lewis, K.F. Austen, “Tryptase from human pulmonary mast cells. Purification and characterization,” J. Biol. Chem. 256(25 November 1981):11939-11943.

2054. C.P. Sommerhoff, W. Bode, G. Matschiner, A. Bergner, H. Fritz, “The human mast cell tryptase tetramer: a fascinating riddle solved by structure,” Biochim. Biophys. Acta 1477(7 March 2000):75-89; C.P. Sommerhoff, W. Bode, P.J. Pereira, M.T. Stubbs, J. Sturzebecher, G.P. Piechottka, G. Matschiner, A. Bergner, “The structure of the human betaII-tryptase tetramer: fo(u)r better or worse,” Proc. Natl. Acad. Sci. (USA) 96(28 September 1999):10984-10991.

2055. V. Patella, G. deCrescenzo, O. Marino, G. Spadaro, A. Genovese, G. Marone, “Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells,” Int. Arch. Allergy Immunol. 111(September 1996):23-29; G. Marone, F. Granata, G. Spadaro, A.M. Onorati, M. Triggiani, “Antiinflammatory effects of oxatomide,” J. Investig. Allergol. Clin. Immunol. 9(July-August 1999):207-214.

2056. S. Di Marco, J.P. Priestle, “Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system,” Structure 5(15 November 1997):1465-1474.

2057. K.D. Rice, R.D. Tanaka, B.A. Katz, R.P. Numerof, W.R. Moore, “Inhibitors of tryptase for the treatment of mast cell-mediated diseases,” Curr. Pharm. Des. 4(October 1998):381-396.

2058. H. Chan, K.C. Elrod, R.P. Numerof, S. Sideris, J.M. Clark, “Expression and characterization of recombinant mast cell tryptase,” Protein Expr. Purif. 15(April 1999):251-257.

2059. M. Koltai, P.G. Braquet, “Platelet-activating factor antagonists,” Clin. Rev. Allergy 12(Winter 1994):361-380.

2060. J.B. Summers, D.H. Albert, “Platelet activating factor antagonists,” Adv. Pharmacol. 32(1995):67-168.

2061. J.M. Negro Alvarez, J.C. Miralles Lopez, J.L. Ortiz Martinez, A. Abellan Aleman, R. Rubio del Barrio, “Platelet-activating factor antagonists,” Allergol. Immunopathol. (Madr) 25(September-October 1997):249-258.

2062. P.V. Peplow, “Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers,” Prostaglandins Leukot. Essent. Fatty Acids 61(August 1999):65-82.

2063. G. Camussi, C. Tetta, E. Turello, C. Baglioni, “Anti-inflammatory peptides inhibit synthesis of platelet-activating factor,” Prog. Clin. Biol. Res. 349(1990):69-80.

2064. M.A. Smal, S.J. Cooney, B.A. Baldo, “Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation,” J. Lipid Mediat. 4(November 1991):333-341.

2065. F. Snyder, V. Fitzgerald, M.L. Blank, “Biosynthesis of platelet-activating factor and enzyme inhibitors,” Adv. Exp. Med. Biol. 416(1996):5-10.

2066. B.K. Ballmer-Weber, C. Gex-Collet, B. Wuthrich, “Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine,” J. Investig. Allergol. Clin. Immunol. 9(November-December 1999):351-355.

2067. B.F. Gibbs, W. Schmutzler, I.B. Vollrath, P. Brosthardt, U. Braam, H.H. Wolff, G. Zwadlo-Klarwasser, “Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells,” Inflamm. Res. 48(February 1999):86-93.

2068. U. Amon, E. von Stebut, N. Subramanian, H.H. Wolff, “CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils,” Pharmacology 47(September 1993):200-208.

2069. U. Amon, B.F. Gibbs, G. Buss, M. Nitschke, “In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells,” Inflamm. Res. 49(March 2000):112-116; C. Kamei, M. Akagi, M. Mio, K. Kitazumi, K. Izushi, S. Masaki, K. Tasaka, “Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition,” Immunopharmacol. Immunotoxicol. 14(1992):191-205.

2070. J. Kleine-Tebbe, C. Josties, G. Frank, D. Stalleicken, A. Buschauer, W. Schunack, G. Kunkel, B. Czarnetzki, “Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine,” J. Allergy Clin. Immunol. 93(February 1994):494-500.

2071. A. Miadonna, N. Milazzo, M. Lorini, E. Marchesi, A. Tedeschi, “Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils,” Int. Arch. Allergy Immunol. 105(September 1994):12-17.

2072. R.Y. Lin, L.B. Schwartz, A. Curry, G.R. Pesola, R.J. Knight, H.S. Lee, L. Bakalchuk, C. Tenenbaum, R.E. Westfal, “Histamine and tryptase levels in patients with acute allergic reactions; An emergency department-based study,” J. Allergy Clin. Immunol. 106(July 2000):65-71.

2073. A. Linder, K. Strandberg, H. Deuschl, “Variations in histamine concentration in nasal secretion in patients with allergic rhinitis,” Allergy 43(February 1988):119-126.

2074. “Septic Shock,” Crit. Care Clin. 5(January 1989):1-194.

2075. R.M. Hardaway, “A review of septic shock,” Am. Surg. 66(January 2000):22-29.

2076. Thomas J. Evans, ed., Septic Shock: Methods and Protocols, Humana Press, 2000.

2077. James P. Steinberg, W. Lee Hand, “Bacteremia and septic shock,” in J. Willis Hurst, Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston, MA, 1992, pp. 265-269.

2078. P. Krajcsi, W.S. Wold, “Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses,” Semin. Cell Dev. Biol. 9(June 1998):351-358.

2079. D.A. Fox, “Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor,” Arch. Intern. Med. 160(28 February 2000):437-444.

2080. R.E. Jones, L.W. Moreland, “Tumor necrosis factor inhibitors for rheumatoid arthritis,” Bull. Rheum. Dis. 48(1999):1-4; L.W. Moreland, “Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis,” Cleve. Clin. J. Med. 66(June 1999):367-374; L.W. Moreland, “Inhibitors of tumor necrosis factor for rhematoid arthritis,” J. Rheumatol. 26 Suppl. 57(May 1999):7-15.

2081. P. Brouckaert et al, “Inhibition of and sensitization to the lethal effects of tumor necrosis factor,” J. Inflamm. 47(1995-1996):18-26.

2082. R. Hohlfeld, “Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?” Mult. Scler. 1(July 1996):376-378.

2083. R.M. Hardaway, “Traumatic shock alias posttrauma critical illness,” Am. Surg. 66(March 2000):284-290.

2084. Bruce Beutler, Steven M. Beutler, “The Pathogenesis of Fever,” in James B. Wyngaarden, Lloyd H. Smith, Jr., J. Claude Bennett, eds., Cecil Textbook of Medicine, 19th edition, W.B. Saunders Company, Philadelphia, PA, 1992, pp. 1568-1571.

2085. Theodore Hersh, “Perforation of the esophagus,” in J. Willis Hurst, ed., Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston MA, 1992, pp. 1490-1492.

2086. B.L. Strom, S.L. West, E. Sim, J.L. Carson, “The epidemiology of the acute flank pain syndrome from suprofen,” Clin. Pharmacol. Ther. 46(December 1989):693-699.

2087. F.J. Ruiz Marcellan, L. Ibarz Servio, M. Ramon Dalmau, “Treatment of lithiasis in the patient with a solitary kidney,” Eur. Urol. 15(1988):13-17.

2088. J.A. Mompo Sanchis, A. Fernandez Rodriguez, E. Tormos Perez, “Extracorporeal shockwave lithotripsy in patients with a single kidney,” Arch. Esp. Urol. 42(1989):31-37 (Suppl 1).

2089. M. Shigeta, M. Hayashi, M. Igawa, “Fever after extracorporeal shock wave lithotripsy for patients with upper urinary tract calculi associated with bacteriuria before treatment,” Eur. Urol. 27(1995):121-123.

2090. C.B. Saper, C.D. Breder, “The neurologic basis of fever,” N. Engl. J. Med. 330(30 June 1994):1880-1886.

2091. Henry C. Mellette, B.K. Hutt, S.I. Askovitz, Steven M. Horvath, “Diurnal Variations in Body Temperature,” J. Appl. Physiol. 3(1951):665-675.

2092. P. Webb, “The physiology of heat regulation,” Am. J. Physiol. 268(April 1995):R838-R850.

2093. C. Bruce Wenger, James D. Hardy, “Chapter 4. Temperature Regulation and Exposure to Heat and Cold,” in Justus F. Lehmann, ed., Therapeutic Heat and Cold, Fourth Edition, Williams & Wilkins, Baltimore, MD, 1990, pp. 150-178.

2094. Morton N. Swartz, Harvey B. Simon, “Chapter XXIV. Pathophysiology of Fever and Fever of Undetermined Origin,” July 1996;

2095. H.B. Simon, “Hyperthermia,” N. Engl. J. Med. 329(12 August 1993):483-487.

2096. C.A. Dinarello, J.G. Cannon, S.M. Wolff, “New concepts on the pathogenesis of fever,” Rev. Infect. Dis. 10(January-February 1988):168-189.

2097. Thomas Hale Ham, Shu Chu Shen, Eleanor M. Fleming, W.B. Castle, “Studies on the Destruction of Red Blood Cells. IV. Thermal Injury...,” Blood 3(1948):373-403.

2098. Henry N. Wagner, Jr, Mohamed A. Razzak, Robert A. Gaertner, Winston P. Caine, Jr., O. Thomas Feagin, “Removal of Erythrocytes from the Circulation,” Arch. Intern. Med. 110(1962):90-97.

2099. Gavin Pearson, “Precision Milling of Teeth for Dental Caries,” in Richard R.H. Coombs, Dennis W. Robinson, eds., Nanotechnology in Medicine and the Biosciences, Gordon & Breach Publishers, Netherlands, 1996, pp. 195-208.


Last updated on 16 April 2004